[
  {
    "ts": null,
    "headline": "Xencor Stock Earns Relative Strength Rating Upgrade",
    "summary": "A Relative Strength Rating upgrade for Xencor shows improving technical performance. Will it continue?",
    "url": "https://finnhub.io/api/news?id=9f1b797942f3ec914f1ca337cc13ec6e033d39d92604b497d896635f1126a11c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760636415,
      "headline": "Xencor Stock Earns Relative Strength Rating Upgrade",
      "id": 137122689,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "A Relative Strength Rating upgrade for Xencor shows improving technical performance. Will it continue?",
      "url": "https://finnhub.io/api/news?id=9f1b797942f3ec914f1ca337cc13ec6e033d39d92604b497d896635f1126a11c"
    }
  },
  {
    "ts": null,
    "headline": "Incyte (INCY) Stock Is Up, What You Need To Know",
    "summary": "Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) jumped 1.5% in the afternoon session after the company announced Health Canada's approval of its Opzelura cream for treating atopic dermatitis in children.",
    "url": "https://finnhub.io/api/news?id=38fd18ac7813e0535edda6ebbbc77ed1c505091b242b7a7760e6586db09f3bf6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760631965,
      "headline": "Incyte (INCY) Stock Is Up, What You Need To Know",
      "id": 137122690,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) jumped 1.5% in the afternoon session after the company announced Health Canada's approval of its Opzelura cream for treating atopic dermatitis in children.",
      "url": "https://finnhub.io/api/news?id=38fd18ac7813e0535edda6ebbbc77ed1c505091b242b7a7760e6586db09f3bf6"
    }
  },
  {
    "ts": null,
    "headline": "INCY or ARGX: Which Is the Better Value Stock Right Now?",
    "summary": "INCY vs. ARGX: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=45154218c62e6274cdaffee3e2c5c14482bb58ab37fb19d7d46f2701534bc404",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760629202,
      "headline": "INCY or ARGX: Which Is the Better Value Stock Right Now?",
      "id": 137122691,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "INCY vs. ARGX: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=45154218c62e6274cdaffee3e2c5c14482bb58ab37fb19d7d46f2701534bc404"
    }
  }
]